“And lastly. Its "UP TO" 10 MILL, not 10mill.....via the S1....they need to sell A LOT OF SHARES TO RAISE THAT!!!!!! !
Ok so first of all... this is as needed financing. They are not selling $10mil in shares all at once lol. The reality is the higher the stock price is the less shares will be sold. I’m certain that they will not use it all either, but for an emerging company it’s good to have.
The financing will be used to begin clinical trials for Adva-27a and pay $300k to manufacture 2 pounds of it.
Imo When they begin clinical trials.... based on the preclinical trials this stock will SOAR$
Adva-27a Clinical Trials Plans....
Adva-27a’s initial indication for Phase I clinical trials will be pancreatic cancer. We are planning to conduct our clinical trials at McGill University’s Jewish General Hospital in Montreal, Canada. All aspects of the planned clinical trials in Canada will employ FDA standards at all levels. We estimate that it will take approximately 18 to 24 months from start to finish. Following successful completion of Phase I clinical trials, it is likely that we will be required to make Adva-27a available to patients under the “compassionate-use” guidelines.
News 
Market Data 
Discover 
